Article
Published 15 Aug 2025
FDA In Flux — August 2025 Newsletter
Mintz
Your search returned 6,358 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 15 Aug 2025
Generative AI Can Be A Tool For Bioprocessing Quality Assurance
Foley Hoag LLP
Article
Published 14 Aug 2025
Reflections On The 12th Annual Summit For Women Leaders In Life Sciences Law
Axinn Veltrop & Harkrider
Article
Published 14 Aug 2025
Final Judgment Of Non-Infringement Entered In Alnylam V. Pfizer Vaccine Patent Dispute
Goodwin Procter LLP
Article
Published 14 Aug 2025
EC Begins Public Consultation On Biotech Act
Bergeson & Campbell
Article
Published 14 Aug 2025
False Claims Act Settlements To Know From The First Half Of 2025
Bass, Berry & Sims
Article
Published 14 Aug 2025
Iowa Overhauls Business Tax Incentives: What Companies Need To Know
BrownWinick Law
Article
Published 13 Aug 2025
The Hidden Legal Risks In Healthcare AI Implementation: What Medical Practice CEOs Need To Know
Michael Best
Article
Published 12 Aug 2025
United States v. Schena: EKRA's Debut At The Ninth Circuit
Steptoe LLP
Article
Published 12 Aug 2025
Texas Struggles To Rein In 'Nuclear Verdicts' As Senate Bill 30 Fails
Phelps Dunbar LLP
Article
Published 12 Aug 2025
The Healthcare Crossroads: Navigating The Impact Of Trump's 2025 Tax Bill
Ankura Consulting Group LLC
Article
Published 12 Aug 2025
FDA Okays Continued PFAS Use In Medical Devices: Says Unlikely To Cause Harm
Arnold & Porter
Article
Published 12 Aug 2025
White House Announces New Efforts On Most-Favored Nation Drug Pricing
Manatt, Phelps & Phillips LLP
Article
Published 12 Aug 2025
FDA Launches PreCheck Program To Accelerate Onshoring Of Drug Manufacturing Facilities
Foley Hoag LLP
Article
Published 11 Aug 2025
The European Commission Publishes An EU Life Sciences Strategy
Arnold & Porter
Article
Published 11 Aug 2025
FDA Moves Forward On Fluoropolymers
Akin Gump Strauss Hauer & Feld LLP
Article
Published 11 Aug 2025
FDA Leads The Way On Fluoropolymers
Akin Gump Strauss Hauer & Feld LLP
Article
Published 8 Aug 2025
Implications Of FDA's "Radical Transparency" Plan For Complete Response Letters
Arnold & Porter
Article
Published 8 Aug 2025
USDA Seeks Public Comment On Reorganization Plan
Bergeson & Campbell
Article
Published 8 Aug 2025
PBM Audits: Assessment Of Escalating Trends And Strategies For Pharmacies
Buchanan Ingersoll & Rooney PC